SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Yeh Y, Ho P, Chen C, Kuo S, Liang C, Ma K, Shiue C, Huang W, Cheng C, Wang T, Lu R, Huang S. Int. J. Neuropsychopharmacol. 2014; ePub(ePub): ePub.

Affiliation

Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan hsy@ndmctsgh.edu.tw.

Copyright

(Copyright © 2014, Cambridge University Press)

DOI

10.1093/ijnp/pyu065

PMID

25522405

Abstract

Much evidence supports the role of the serotonin transporter (SERT) in the pathophysiology and pharmacotherapy of major depressive disorder (MDD) and suicidal behaviors. In this study, we recruited 17 antidepressant-naïve patients with MDD and 17 age- and gender-matched healthy controls. SERT availability was measured in vivo with N,N-dimethyl-2-(2-amino-4-[(18)F]fluorophenylthio)benzylamine (4-[(18)F]-ADAM) positron emission tomography (PET) imaging. The 21-item Hamilton Depression Rating Scale (HDRS) and Beck Scale for Suicide Ideation were used to assess the severity of depression and the intent of suicide ideation prior to PET imaging. All subjects with MDD were in a current state of depression with HDRS scores ≧ 18. Subjects who attempted suicide within two weeks of the study onset were recruited in the depressed suicidal group (n = 8). Subjects with MDD who denied any prior suicide attempt were recruited into the depressed non-suicidal group (n = 9). A significant reduction of SERT availability in the midbrain, thalamus, and striatum was noted in the MDD group relative to the control group (Bonferroni-adjusted p-value < 0.05). Moreover, this effect was more pronounced in depressed suicidal group compared to the control group (Bonferroni-adjusted p-value < 0.01). Relative to both depressed non-suicidal and control groups, the depressed suicidal group showed an increased prefrontal cortex (PFC)/midbrain SERT binding ratio (Bonferroni-adjusted p-value < 0.01). This study suggests an incongruent reduction of PFC SERT binding relative to midbrain might discriminate depressed suicide attempters from non-attempters in patients with MDD and may be involved in the pathophysiology of suicide behaviors.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print